Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus

Journal of Applied Physiology

Volumn 114, Issue 1, 2013, Pages 119-130

  Stettner, Georg M ^a   Kubin, Leszek ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Almorexant; Blood pressure; Motoneurons; Upper airway; Wakefulness

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE RECEPTOR; NORADRENALIN; OREXIN RECEPTORS; PYRIDAZINE DERIVATIVE;

ANIMAL; ARTERIAL PRESSURE; ARTICLE; BREATHING RATE; DRUG ANTAGONISM; DRUG EFFECT; HEART RATE; HYPOGLOSSAL NERVE; MALE; METABOLISM; MOTONEURON; PHYSIOLOGY; POSTERIOR HYPOTHALAMUS; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ARTERIAL PRESSURE; GABA ANTAGONISTS; HEART RATE; HYPOGLOSSAL NERVE; HYPOTHALAMUS, POSTERIOR; MALE; MOTOR NEURONS; NOREPINEPHRINE; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GABA; RECEPTORS, NEUROPEPTIDE; RESPIRATORY RATE;

EID: 84871803589     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00965.2012     Document Type: Article

References (70)

1. Adamantidis A, de Lecea L. Sleep and metabolism: shared circuits, new connections. Trends Endocrinol Metab 19: 362-370, 2008.
2. Alam MN, Kumar S, Bashir T, Suntsova N, Methippara MM, Szymusiak R, McGinty D. GABA-mediated control of hypocretin-but not melanin-concentrating hormone-immunoreactive neurones during sleep in rats. J Physiol 563: 569-582, 2005.
3. Aldes LD. Subcompartmental organization of the ventral (protrusor) compartment in the hypoglossal nucleus of the rat. J Comp Neurol 353: 89-108, 1995.
4. Aldes LD, Chapman ME, Chronister RB, Haycock JW. Sources of noradrenergic afferents to the hypoglossal nucleus in the rat. Brain Res Bull 29: 931-942, 1992.
5. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleepwaking cycle. J Neurosci 1: 876-886, 1981.
6. Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 24: 4469-4477, 2004.
7. Bittencourt JC. Anatomical organization of the melanin-concentrating hormone peptide family in the mammalian brain. Gen Comp Endocrinol 172: 185-197, 2011.
8. Bourgin P, Huitrón-Reséndiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20: 7760-7765, 2000.
9. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13: 150-155, 2007.
10. Brown RE, Sergeeva O, Eriksson KS, Haas HL. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40: 457-459, 2001.
11. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451, 1999.
12. Chen CT, Hwang LL, Chang JK, Dun NJ. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol 278: R692-R697, 2000.
13. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96: 748-753, 1999.
14. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 369: 499-511, 2007.
15. de Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Bartlett FSI, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
16. De Novellis V, Stotz-Potter EH, Morin SM, Rossi F, DiMicco JA. Hypothalamic sites mediating cardiovascular effects of microinjected bicuculline and EAAs in rats. Am J Physiol Regul Integr Comp Physiol 269: R131-R140, 1995.
17. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 90: 47-112, 2010.
18. DiMicco JA, Abshire VM. Evidence for GABAergic inhibition of a hypothalamic sympathoexcitatory mechanism in anesthetized rats. Brain Res 402: 1-10, 1987.
19. DiMicco JA, Abshire VM, Hankins KD, Sample RH, Wible JH Jr. Microinjection of GABA antagonists into posterior hypothalamus elevates heart rate in anesthetized rats. Neuropharmacology 25: 1063-1066, 1986.
20. Dobbins EG, Feldman JL. Differential innervation of protruder and retractor muscles of the tongue in rat. J Comp Neurol 357: 376-394, 1995.
21. Dutschmann M, Kron M, Mörschel M, Gestreau C. Activation of orexin B receptors in the pontine Kölliker-Fuse nucleus modulates preinspiratory hypoglossal motor activity in rat. Respir Physiol Neurobiol 159: 232-235, 2007.
22. Economo CV. Sleep as a problem of localization. J Nerv Ment Dis 71: 249-259, 1930.
23. Fenik V, Fenik P, Kubin L. A simple cuff electrode for nerve recording and stimulation in acute experiments on small animals. J Neurosci Methods 116: 147-150, 2001.
24. Fenik V, Marchenko V, Janssen P, Davies RO, Kubin L. A5 cells are silenced when REM sleep-like signs are elicited by pontine carbachol. J Appl Physiol 93: 1448-1456, 2002.
25. Fenik VB, Rukhadze I, Kubin L. Antagonism of alpha1-adrenergic and serotonergic receptors in the hypoglossal motor nucleus does not prevent motoneuronal activation elicited from the posterior hypothalamus. Neurosci Lett 462: 80-84, 2009.
26. Fenik VB, Rukhadze I, Kubin L. Orexin 1 and 2 receptor antagonist, almorexant, attenuates activation of hypoglossal (XII) motoneurons elicited by bicuculline from the posterior lateral hypothalamus (Abstract). Sleep 32, Suppl: A18, 2009.
27. Fung SJ, Yamuy J, Sampogna S, Morales FR, Chase MH. Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study. Brain Res 903: 257-262, 2001.
28. Gestreau C, Bevengut M, Dutschmann M. The dual role of the orexin/ hypocretin system in modulating wakefulness and respiratory drive. Curr Opin Pulm Med 14: 512-518, 2008.
29. Goutagny R, Luppi PH, Salvert D, Gervasoni D, Fort P. GABAergic control of hypothalamic melanin-concentrating hormone-containing neurons across the sleep-waking cycle. Neuroreport 16: 1069-1073, 2005.
30. Henny P, Jones BE. Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. J Comp Neurol 499: 645-661, 2006.
31. Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS, van den Pol AN. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415: 145-159, 1999.
32. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285: R581-R593, 2003.
33. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton Neurosci 161: 20-27, 2011.
34. Kuwaki T, Li A, Nattie E. State-dependent central chemoreception: a role of orexin. Respir Physiol Neurobiol 173: 223-229, 2010.
35. Kuwaki T, Zhang W. Orexin neurons as arousal-associated modulators of central cardiorespiratory regulation. Respir Physiol Neurobiol 174: 43-54, 2010.
36. Li A, Nattie E. Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol 588: 2935-2944, 2010.
37. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376, 1999.
38. Lu JW, Fenik VB, Branconi JL, Mann GL, Rukhadze I, Kubin L. Disinhibition of perifornical hypothalamic neurones activates noradrenergic neurones and blocks pontine carbachol-induced REM sleep-like episodes in rats. J Physiol 582: 52-67, 2007.
39. Machado BH, Bonagamba LG, Dun SL, Kwok EH, Dun NJ. Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats. Regul Pept 104: 75-81, 2002.
40. Manaker S, Tischler LJ. Origin of serotonergic afferents to the hypoglossal nucleus in the rat. J Comp Neurol 334: 466-476, 1993.
41. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6-25, 2001.
42. McGregor R, Damian A, Fabbiani G, Torterolo P, Pose I, Chase M, Morales FR. Direct hypothalamic innervation of the trigeminal motor nucleus: a retrograde tracer study. Neuroscience 136: 1073-1081, 2005.
43. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 89: 1571-1579, 1992.
44. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39-40, 2000.
45. Nixon JP, Smale L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav Brain Funct 3: 28, 2007.
46. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Amsterdam: Elsevier, 2007.
47. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6: 991-997, 2000.
48. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff T. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015, 1998.
49. Remmers JE, DeGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 44: 931-938, 1978.
50. Robinson TE, Whishaw IQ. Effects of posterior hypothalamic lesions on voluntary behavior and hippocampal electroencephalograms in the rat. J Comp Physiol Psychol 86: 768-786, 1974.
51. Rukhadze I, Fenik VB, Benincasa KE, Price A, Kubin L. Chronic intermittent hypoxia alters density of aminergic terminals and receptors in the hypoglossal motor nucleus. Am J Respir Crit Care Med 182: 1321-1329, 2010.
52. Rukhadze I, Kubin L. Differential pontomedullary catecholaminergic projections to hypoglossal motor nucleus and viscerosensory nucleus of the solitary tract. J Chem Neuroanat 33: 23-33, 2007.
53. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 1, 1998.
54. Sallanon M, Denoyer M, Kitahama K, Aubert C, Gay N, Jouvet M. Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience 32: 669-683, 1989.
55. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24: 726-731, 2001.
56. Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 51: 243-266, 2011.
57. Skofitsch G, Jacobowitz DM, Zamir N. Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull 15: 635-649, 1985.
58. Stettner GM, Fenik VB, Kubin L. Effect of chronic intermittent hypoxia on noradrenergic activation of hypoglossal motoneurons. J Appl Physiol 112: 305-312, 2012.
59. Stettner GM, Kubin L. Activation of hypoglossal (XII) motoneurons from the perifornical region of the posterior hypothalamus depends on orexinergic (ORX) activation in both the hypothalamus and the XII nucleus. Program No. 505.05. In: 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2011. [http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey- 335dd93c-79e8-4d7f-ac0b-dc7acc69c2ad&cKey-146d9dec-aa8a-4960-8efa- f0f2a950596c&mKey-{8334BE29-8911-4991-8C31-32B32DD5E6C8}].
60. Suratt PM, McTier RF, Wilhoit SC. Upper airway muscle activation is augmented in patients with obstructive sleep apnea compared with that in normal subjects. Am Rev Respir Dis 137: 889-894, 1988.
61. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469-474, 2000.
62. Trulson ME, Trulson VM. Activity of nucleus raphe pallidus neurons across the sleep-waking cycle in freely moving cats. Brain Res 237: 232-237, 1982.
63. van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19: 3171-3182, 1999.
64. Volgin DV, Saghir M, Kubin L. Developmental changes in the orexin 2 receptor mRNA in hypoglossal motoneurons. Neuroreport 13: 433-436, 2002.
65. Waldrop TG, Bauer RM, Iwamoto GA. Microinjection of GABA antagonists into the posterior hypothalamus elicits locomotor activity and a cardiorespiratory activation. Brain Res 444: 84-94, 1988.
66. Woch G, Kubin L. Non-reciprocal control of rhythmic activity in respiratory-modulated XII motoneurons. Neuroreport 6: 2085-2088, 1995.
67. Yamanaka A, Tabuchi S, Tsunematsu T, Fukazawa Y, Tominaga M. Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci 30: 12642-12652, 2010.
68. Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 24: 5336-5345, 2004.
69. Young JK, Wu M, Manaye KF, Kc P, Allard JS, Mack SO, Haxhiu MA. Orexin stimulates breathing via medullary and spinal pathways. J Appl Physiol 98: 1387-1395, 2005.
70. Ziegler DR, Cullinan WE, Herman JP. Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. J Comp Neurol 448: 217-229, 2002.